Disruption of an env tyrosine-dependent sorting signal does not affect susceptibility of HIV-1 to cytotoxic T lymphocytes

AIDS

Volumn 23, Issue 11, 2009, Pages 1449-1451

  Cruz, Justin De La ^a   Ali, Ayub ^a   Ng, Hwee L ^a   Yang, Otto O ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE;

CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; LETTER; PRIORITY JOURNAL; PROTEIN MOTIF; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS MUTATION; VIRUS REPLICATION;

EID: 68449085123     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832dbf91     Document Type: Letter

References (20)

1. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992; 258:1938-1941.
2. Shacklett BL, Weber CJ, Shaw KE, Keddie EM, Gardner MB, Sonigo P, Luciw PA. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques. J Virol 2000; 74:5836-5844.
3. Fultz PN, Vance PJ, Endres MJ, Tao B, Dvorin JD, Davis IC, et al. In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol 2001; 75:278-291.
4. Berlioz-Torrent C, Shacklett BL, Erdtmann L, Delamarre L, Bouchaert I, Sonigo P, et al. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J Virol 1999; 73:1350-1361.
5. Blot G, Janvier K, Le Pase S, Benarous R, Berlioz-Torrent C. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for Env incorporation into virions and infectivity. J Virol 2003; 77:6931-6945.
6. Hoxie J. Attenuated SIV models and protection from pathogenic heterologous challenges. In: Proceedings of the Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008. Boston, MA: CCO.
7. AN A, Jamieson BD, Yang OO. Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses. J Virol Methods 2003; 110:137-142.
8. Yang OO, Sarkis PT, Ali A, Harlow JD, Brander C, Kalams SA, Walker BD. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med 2003; 197:1365-1375.
9. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunoge-netics 1985; 21:235-246.
10. Yang OO, Kalams SA, Trocha A, Cao H, Luster A, Johnson RP, Walker BD. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class l-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 1997; 71:3120-3128.
11. Bennett MS, Ng HL, AN A, Yang OO. Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect crossclade antiviral activity. J Infect Dis 2008; 197:390-397.
12. Adnan S, Balamurugan A, Trocha A, Bennett MS, Ng HL, Ali A, et al. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 2006; 108:3414-3419.
13. Johnson RP, Desrosiers RC. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol 1998; 10:436-443.
14. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, Van Rompay KK, et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 1994; 68:7021-7029.
15. Wyand MS, Manson K, Montefiori DC, Lifson JD, Johnson RP, Desrosiers RC. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 1999; 73:8356-8363.
16. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998; 72:164-169.
17. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-998.
18. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-860.
19. Stevceva L, Yoon V, Anastasiades D, Poznansky MC. Immune responses to HIV Gp120 that facilitate viral escape. Curr HIV Res 2007; 5:47-54.
20. Stevceva L, Yoon V, Carville A, Pacheco B, Santosuosso M, Korioth-Schmitz B, et al. The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo. J Immunol 2008; 181:5510-5521.